7VIC
The crystal structure of SARS-CoV-2 3C-like protease in complex with a traditional Chinese Medicine Inhibitors
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SEALED TUBE |
Source details | OXFORD DIFFRACTION NOVA |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2021-04-29 |
Detector | OXFORD ONYX CCD |
Wavelength(s) | 1.5406 |
Spacegroup name | I 1 2 1 |
Unit cell lengths | 52.178, 81.411, 91.218 |
Unit cell angles | 90.00, 96.14, 90.00 |
Refinement procedure
Resolution | 24.499 - 2.100 |
Rwork | 0.216 |
R-free | 0.24220 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6lu7 |
RMSD bond length | 0.002 |
RMSD bond angle | 1.220 |
Data reduction software | CrysalisPro |
Data scaling software | CrysalisPro |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 24.499 | 2.180 |
High resolution limit [Å] | 2.100 | 2.100 |
Rmerge | 0.129 | |
Number of reflections | 22123 | 2204 |
<I/σ(I)> | 10.5 | |
Completeness [%] | 99.7 | |
Redundancy | 4.4 | |
CC(1/2) | 0.991 | 0.814 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 289 | 100 mM MES, pH6, 12% PEG 6000, 0.5% DMSO |